vs

Side-by-side financial comparison of Avalon GloboCare Corp. (ALBT) and CKX LANDS, INC. (CKX). Click either name above to swap in a different company.

Avalon GloboCare Corp. is the larger business by last-quarter revenue ($350.1K vs $232.6K, roughly 1.5× CKX LANDS, INC.). CKX LANDS, INC. runs the higher net margin — 71.5% vs -72.6%, a 144.1% gap on every dollar of revenue. On growth, CKX LANDS, INC. posted the faster year-over-year revenue change (35.8% vs 1.4%). Over the past eight quarters, Avalon GloboCare Corp.'s revenue compounded faster (4.4% CAGR vs -42.0%).

Avalon GloboCare Corp. is a global biotechnology and healthcare service provider specializing in cell and gene therapy, regenerative medicine solutions, and translational medical research. It operates across North America and Asia, serving clinical, research and commercial healthcare stakeholders with tailored offerings.

CKX Lands, Inc. is a U.S.-based land management and natural resources company. It owns and manages land parcels across North America, with core business segments including timber production, mineral rights leasing, agricultural land rental, and recreational land access services for individual and commercial customers.

ALBT vs CKX — Head-to-Head

Bigger by revenue
ALBT
ALBT
1.5× larger
ALBT
$350.1K
$232.6K
CKX
Growing faster (revenue YoY)
CKX
CKX
+34.4% gap
CKX
35.8%
1.4%
ALBT
Higher net margin
CKX
CKX
144.1% more per $
CKX
71.5%
-72.6%
ALBT
Faster 2-yr revenue CAGR
ALBT
ALBT
Annualised
ALBT
4.4%
-42.0%
CKX

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
ALBT
ALBT
CKX
CKX
Revenue
$350.1K
$232.6K
Net Profit
$-254.3K
$166.3K
Gross Margin
Operating Margin
-21.8%
48.7%
Net Margin
-72.6%
71.5%
Revenue YoY
1.4%
35.8%
Net Profit YoY
84.9%
207.3%
EPS (diluted)
$-0.06
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALBT
ALBT
CKX
CKX
Q3 25
$350.1K
$232.6K
Q2 25
$350.4K
$135.9K
Q1 25
$349.8K
$348.2K
Q4 24
$345.8K
$180.6K
Q3 24
$345.2K
$171.3K
Q2 24
$327.9K
$1.0M
Q1 24
$314.6K
$141.8K
Q4 23
$321.3K
$690.4K
Net Profit
ALBT
ALBT
CKX
CKX
Q3 25
$-254.3K
$166.3K
Q2 25
$-13.5M
$161.0K
Q1 25
$-2.5M
$115.6K
Q4 24
Q3 24
$-1.7M
$54.1K
Q2 24
$-2.1M
$565.3K
Q1 24
$-1.4M
$-401.3K
Q4 23
$-9.6M
Operating Margin
ALBT
ALBT
CKX
CKX
Q3 25
-21.8%
48.7%
Q2 25
-1109.6%
Q1 25
-516.5%
32.2%
Q4 24
-41.9%
Q3 24
-367.9%
-9.9%
Q2 24
-458.8%
62.9%
Q1 24
-268.0%
-307.8%
Q4 23
-3047.1%
52.0%
Net Margin
ALBT
ALBT
CKX
CKX
Q3 25
-72.6%
71.5%
Q2 25
-3840.9%
118.5%
Q1 25
-709.6%
33.2%
Q4 24
Q3 24
-486.5%
31.6%
Q2 24
-650.2%
55.0%
Q1 24
-434.7%
-282.9%
Q4 23
-2973.7%
EPS (diluted)
ALBT
ALBT
CKX
CKX
Q3 25
$-0.06
$0.08
Q2 25
$-6.22
$0.08
Q1 25
$-1.43
$2027032.00
Q4 24
$-1991337.18
Q3 24
$-1.82
$0.03
Q2 24
$-2.85
$0.27
Q1 24
$-1.86
$1991337.00
Q4 23
$-21.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALBT
ALBT
CKX
CKX
Cash + ST InvestmentsLiquidity on hand
$333.9K
Total DebtLower is stronger
Stockholders' EquityBook value
$-4.5M
$18.9M
Total Assets
$9.1M
$19.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALBT
ALBT
CKX
CKX
Q3 25
$333.9K
Q2 25
$201.5K
Q1 25
$1.4M
Q4 24
Q3 24
$1.0M
Q2 24
$200.6K
Q1 24
$305.5K
Q4 23
$285.4K
Stockholders' Equity
ALBT
ALBT
CKX
CKX
Q3 25
$-4.5M
$18.9M
Q2 25
$-7.1M
$18.7M
Q1 25
$-3.9M
$18.7M
Q4 24
$18.6M
Q3 24
$5.4M
$18.6M
Q2 24
$4.4M
$18.5M
Q1 24
$6.1M
$18.0M
Q4 23
$7.4M
$18.3M
Total Assets
ALBT
ALBT
CKX
CKX
Q3 25
$9.1M
$19.2M
Q2 25
$8.0M
$18.9M
Q1 25
$10.6M
$19.0M
Q4 24
$18.8M
Q3 24
$19.6M
$18.7M
Q2 24
$19.5M
$19.0M
Q1 24
$20.3M
$18.4M
Q4 23
$20.6M
$18.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALBT
ALBT
CKX
CKX
Operating Cash FlowLast quarter
$-1.4M
$242.3K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.46×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALBT
ALBT
CKX
CKX
Q3 25
$-1.4M
$242.3K
Q2 25
$-1.2M
$-24.6K
Q1 25
$-1.8M
$118.7K
Q4 24
$-1.1M
$97.4K
Q3 24
$-1.9M
$-246.5K
Q2 24
$-1.1M
$691.7K
Q1 24
$-915.7K
$-337.8K
Q4 23
$-796.3K
$624.5K
Free Cash Flow
ALBT
ALBT
CKX
CKX
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
$-796.3K
FCF Margin
ALBT
ALBT
CKX
CKX
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
-247.8%
Capex Intensity
ALBT
ALBT
CKX
CKX
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
0.0%
Cash Conversion
ALBT
ALBT
CKX
CKX
Q3 25
1.46×
Q2 25
-0.15×
Q1 25
1.03×
Q4 24
Q3 24
-4.56×
Q2 24
1.22×
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons